Advirna is developing innovative solutions for oligonucleotide delivery to cells ex-vivo and in-vivo.


Our technology platform - self-deliverable RNAi technology (sdRNAi) allows efficient knock down of genes in hard-to-transfect cell lines ex vivo and in vivo using RNAi interference. sdRNAi technology is based on the deep chemical modification of siRNAs and allows efficient delivery of RNAi into all cell types ex-vivo and to certain organs in vivo. sdRNAi delivery does not require the use of any additional formulation or delivery techniques.